Identification of multi-drug resistant Acinetobacter baumannii phage YZ2 and evaluation of its therapeutic efficacy in vivo and in vitro
Open Access
- 24 November 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1657539
Abstract
Introduction: Carbapenem-resistant Acinetobacter baumannii (CRAB) has recently become an important pathogen in clinically acquired infections, making treatment more challenging. Methods: The treatment of bacterial infections may improve with the development of phage therapy and phage-antibiotic combination therapy. Here, we reported a novel phage YZ2 that has a double-stranded DNA genome of 40,181 bp with 37.93% GC content. A total of 46 open reading frames (ORFs) and no virulence or antimicrobial resistance genes were annotated in the genome of phage YZ2. Phage YZ2 is a novel member of the Autographiviridae , with a latency period of approximately 20 min and a burst size of approximately 134 phage particles per infected host cell. Results: The in vitro antibacterial results demonstrated that YZ2 could rapidly eliminate host bacteria at a low multiplicity of infection, showing strong bactericidal efficacy. In vivo , YZ2 significantly increased the survival rate of A. baumannii -infected Galleria mellonella larvae from 10 to 100% within 72 h. Discussion: Moreover, compared with the use of phage or polymyxin B alone, the combined use of phage YZ2 and polymyxin B can significantly increased the survival rate of G. mellonella larvae and had a synergistic effect. These results imply that phage YZ2 has the potential for development as an antimicrobial agent.Keywords
This publication has 86 references indexed in Scilit:
- The emerging role of the gut microbiota and its application in inflammatory bowel diseaseBiomedicine & Pharmacotherapy, 2024
- Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018–2022Journal of Global Antimicrobial Resistance, 2024
- Phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical studyEBioMedicine, 2022
- Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitalsMolecular Biology Reports, 2021
- Practical Advice on the One-Step Growth Curve2017
- Isolation, genome sequencing and functional analysis of two T7-like coliphages of avian pathogenic Escherichia coliGene, 2016
- Genetic Insertions and Diversification of the PolB-Type DNA Polymerase (gp43) of T4-Related PhagesJournal of Molecular Biology, 2009
- Enumeration of Bacteriophages by Double Agar Overlay Plaque Assay2009
- Phage Host Range and Efficiency of Plating2009
- Bacteriophages: an appraisal of their role in the treatment of bacterial infectionsInternational Journal of Antimicrobial Agents, 2007